Author Archives: Editor

Elsevier (Sinister Evil) Medical Journals : Puts Monsanto as Associate Editor to force retraction of GMO study

antiElsevier3-320x319Fast forward to September 2012, when the scientific journal Food and Chemical Toxicology (FCT) published a study that caused an international storm (Séralini, et al. 2012). The study, led by Prof Gilles-Eric Séralini of the University of Caen, France, suggested a Monsanto genetically modified (GM) maize, and the Roundup herbicide it is grown with, pose serious health risks. The two-year feeding study found that rats fed both suffered severe organ damage and increased rates of tumors and premature death. Both the herbicide (Roundup) and the GM maize are Monsanto products. Corinne Lepage, France’s former environment minister, called the study “a bomb”.

Subsequently, an orchestrated campaign was launched to discredit the study in the media and persuade the journal to retract it. Many of those who wrote letters to FCT (which is published by Elsevier) had conflicts of interest with the GM industry and its lobby groups, though these were not publicly disclosed.

The journal did not retract the study. But just a few months later, in early 2013 the FCT editorial board acquired a new “Associate Editor for biotechnology”, Richard E. Goodman. This was a new position, seemingly established especially for Goodman in the wake of the “Séralini affair”.

Richard E. Goodman is professor at the Food Allergy Research and Resource Program, University of Nebraska. But he is also a former Monsanto employee, who worked for the company between 1997 and 2004. While at Monsanto he assessed the allergenicity of the company’s GM crops and published papers on its behalf on allergenicity and safety issues relating to GM food (Goodman and Leach 2004). Read more…

Elsevier also publishes, VACCINE journal and American Journal of Obstetrics and Gynecology (AJOG)

More on Elsevier who publishes over 1000 journals controlling the scientific community:

Elsevier funds NY Congresswoman, Carolyn Maloney to initiate sinister evil bill.. Excerpts

Feb. 2012  Monday, the publisher announced it was withdrawing its support of the Research Works Act, a proposed piece of legislation, sponsored by Congresswoman Carolyn Maloney that would have dropped the requirement that all publicly funded research be open to the public. Upon hearing the news, US Representatives Darrel Issa  and Carolyn Maloney immediately withdrew the bill, killing it.

Elsevier COVER UP & COLLUSION WITH THE CDC of 4,250% increase in abortion reports associated with the push to vaccinate pregnant women with the H1N1 untested Pandemic vaccine. Because of the successful cover up (riveting backstory) pregnant women now receive a flu shot (with no mention of the Thimerosal content) and a Tdap shot…that is 4 vaccine doses while pregnant.

 

 

Emergency Authorization Use: More on the 30 million narcolepsy-causing vaccines FDA/BARDA stockpiling for use on unwitting American Public

imageThe vaccine Pandemrix, (According to GSK, some 30 million doses of the vaccine were administered across Europe and 800 people, mostly children, developed narcolepsy) will be added to the national stockpile.The vaccine will not be available commercially; it will be placed in the U.S. government’s emergency stockpile, FDA said.

Letter of Acceptance from FDA

FDA site: GSK Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted with ASO3.

VLA comment: This newly approved “Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted is like Pandemrix, (Pandemrix, which has not been approved in the United States). It is also made by GSK and is almost identical in structure and has just been approved for our national stockpile. This vaccine contains the adjuvant ASO3 (contains Squalene) and (polysorbate 80) for use on the American people under Emergency Use Authorization*, so you won’t know what’s coming!  Generally unknown,  In June 23, 2011 the FDA approved Novartis FLUAD Influenza vaccine which contains a similiar adjuvant- MF596 (contains Squalene) and (polysorbate 80).

While GSK has acknowledged an association between the vaccine and the narcolepsy cases, it has said there is insufficient evidence to prove the adjuvant (ASO3) was to blame. Scientists believe AS03 may be the culprit in the narcolepsy cases though they have yet to decipher the precise nature of the association. Read article…

Read March 2013 Huffington Post…

GKS: The vaccine will be supplied in a kit consisting of one package containing 50 multidose vials of H5N1 antigen and two packages each containing 25 multidose vials of AS03 adjuvant. Since, as stated in your November 11, 2013, submission, you do not intend to market this product for commercial distribution. (Stockpiling for emergency authorization use). “Supporting the U.S. Government’s capability to help protect Americans against pandemics ranks among GSK’s most important U.S. public-health responsibilities,” said Bruce Innis, Vice President of Vaccines Development for GSK. “H5N1-related illness has thus far been rare, but life-threatening when it has occurred”.

GSK will make this vaccine available in the U.S. only if directed to by the Biomedical Advanced Development and Research Authority (BARDA) in the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response. The GSK H5N1 pandemic influenza vaccine programme has been supported by a development contract (HHSO100200700029C) from BARDA. GSK’s Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted, has also received marketing authorisation in Europe and Canada under the brand names, Pumarix™ and Arepanrix™ H5N1, respectively. Read more…

Pumarix: Glaxo’s super-charged product is the first to show it can confer protection in the event of a pandemic. European regulators have approved it under the brand name Pumarix  (contains Squalene) and (polysorbate 80)

Read more…

Some ingredients of the FDA approved vaccine (Nov. 22, 2013): ASO3, (contains Squalene) (polysorbate 80) & Thimerosal (mercury),

Division of Chemical, Biological, Radiological and Nuclear Medical Countermeasures (CBRN MCM)

Stockpiling Lifesaving MCMs
The Division of CBRN MCMs is responsible for developing and establishing stockpiles of lifesaving vaccines, drugs, and diagnostics against CBRN threats. The Project BioShield Act of 2004 established the Special Reserve Fund (SRF), a one-time appropriation of $5.6 billion (2004 – 2013) to accelerate the research, development and acquisition of MCMs against CBRN threat agents. Eight Project BioShield programs have led to the acquisition of MCMs for the Strategic National Stockpile (SNS). These include an anthrax vaccine for post-exposure prophylaxis, anthrax therapeutics, a novel smallpox vaccine, a smallpox antiviral drug, a botulinum antitoxin, and radiation countermeasures. Read more…

MUST READ…Bioshield Annual Report (2012) 

All Annual Bioshield Reports

*Emergency Use Authorization for Medical Counter-measures– Section 4 of the Act allows the HHSSecretary to issue an Emergency Use Authorization (EUA) after an emergency has been declared by the Secretary as described in the “Statutory Authority”section found on page 7. The EUA declaration justifies the use of a FDA-approved, licensed, or cleared product for an unapproved indication or an unapproved product for an indication over a specified period of time during the emergency.

Gardasil: France: 15 year old girl severly injured (MS): Lawsuit against Sanofi Pasteur

gardasil.gi_1Today, the 22nd November 2013, Mr. Jean-Christophe Coubris, defence lawyer for Marie-Océane, has filed charges with the French public prosecutor in Bobigny, in the outskirts of Paris, against both Laboratoire Sanofi Pasteur MSD and the French authority Agence Nationale du Médicament (ANSM), the French National Medicines Agency, for breach of their manifest duty to ensure safety and for disregard of the precautionary and prevention principles.

An initial injection of Gardasil was administered to Marie-Océane, age 15 at the time, on the 11th of October 2010. A second injection of the vaccine was administered to Marie-Océane on the 13th of December 2010.

The first clinical symptoms appeared in mid-February 2011 and were rapidly diagnosed as acute disseminated encephalomyelitis or multiple sclerosis.

Read more…

Univ. of Sidney, Au. Study: Mercury: neurodegenerative, demyelinating, and psychiatric disorders

Baby-VaccineToxicants enter locus ceruleus neurons selectively, aided by the extensive exposure these neurons haveto CNS capillaries, as well as by stressors that upregulate locus ceruleus activity. The resulting noradrenaline dysfunction affects a wide range of CNS cells and can trigger a number of neurodegenerative (Alzheimer’s, Parkinson’s and motor neuron disease) demyelinating (multiple sclerosis), and psychiatric (major depression and bipolar disorder) conditions. Read Study...

Bill Gates’ Polio Vaccine Program Eradicates Children, Not Polio

oral-polio-vaccine-500x300The CDC Spills The Beans

In 2012, the CDC wrote a press release titled Update on Vaccine-Derived Polioviruses — Worldwide, April 2011–June 2012. They wrote:

“In 1988, the World Health Assembly resolved to eradicate poliomyelitis worldwide. One of the main tools used in polio eradication efforts has been the live, attenuated oral poliovirus vaccine (OPV). This inexpensive vaccine is administered easily by mouth, makes recent recipients resistant to infection by wild polioviruses (WPVs), and provides long-term protection against paralytic disease through durable humoral immunity. Nonetheless, rare cases of vaccine-associated paralytic poliomyelitis can occur both among immunologically normal OPV recipients and their contacts and among persons who are immunodeficient. In addition, vaccine-derived polioviruses (VDPVs) can emerge to cause polio outbreaks in areas with low OPV coverage and can replicate for years in persons who are immunodeficient.” (emphasis added) READ MORE…

Flu shot: 19 year LDS Utah Teen dies after flu vaccine injection


 

chandler-webb-and-his-mom

A month ago, Chandler was his typical happy and healthy self. Gearing up for an LDS mission, he went to a Sandy pediatrician for a physical.
“This was his first flu shot, he never had one before,” his mother, Lori Webb said.
Less than 24 hours later, Chandler became violently ill. “He said he never shook so hard his whole life,” Lori Webb said. “He had the worst headache, throw up.” Read more…

Parents go to trial for Shaken Baby Syndrome: Baby dies having received 21 vaccine doses by 5 months old (9/2012

baby-afterBaby A’s mother told VacTruth that the vaccinations were administered extremely harshly, with the nurse appearing to stab their daughter viciously with a variety of needles. This day…Baby A received eight vaccines in total, the five-in-one vaccine Pentaxim said to protect against diphtheria, tetanus, acellular pertussis, haemophilus influenza type B (Hib) and polio; the hepatitis B vaccine; the rotavirus vaccine; and a vaccine said to protect babies against pneumocococcal and non-typeable haemophilus influenzae disease, Prenevar/Prenvar.

Her mother explained that after her ordeal, Baby A was irritable, upset and had difficulty in settling. That the following day, she was unable to move her legs, which remained hard and swollen around the injection site for several days. Read the rest of the story….

 Listen to the Interview    Help Baby A’s parents fight legal battle http://www.gofundme.com/babyaparents